Overview
Tetsutaro Nagaoka practices practicing medicine in Tokyo, Japan.
Nagaoka is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Pulmonary Hypertension, Lymphofollicular Hyperplasia, Hypertension, and Interstitial Lung Disease.
They are actively involved in clinical research, co-authoring 36 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tetsutaro Nagaoka
Is Tetsutaro Nagaoka a top-rated expert for Pulmonary Hypertension?
MediFind is an objective health platform that identifies experts based on real-world data. Tetsutaro Nagaoka is classified as an Advanced expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tetsutaro Nagaoka participate in research or clinical trials?
Yes. Tetsutaro Nagaoka has published 36 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Tetsutaro Nagaoka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Interstitial Pneumonia
- HypertensionNagaoka isAdvanced. Learn about Hypertension.
- Interstitial Lung DiseaseNagaoka isAdvanced. Learn about Interstitial Lung Disease.
- Lymphofollicular Hyperplasia
- Pulmonary HypertensionNagaoka isAdvanced. Learn about Pulmonary Hypertension.
- Experienced
- AsthmaNagaoka isExperienced. Learn about Asthma.
- COVID-19Nagaoka isExperienced. Learn about COVID-19.
- Diabetic KetoacidosisNagaoka isExperienced. Learn about Diabetic Ketoacidosis.
- Eosinophilic AsthmaNagaoka isExperienced. Learn about Eosinophilic Asthma.
- Idiopathic Pulmonary FibrosisNagaoka isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Langerhans Cell HistiocytosisNagaoka isExperienced. Learn about Langerhans Cell Histiocytosis.
- Lung AdenocarcinomaNagaoka isExperienced. Learn about Lung Adenocarcinoma.
- LymphangioleiomyomatosisNagaoka isExperienced. Learn about Lymphangioleiomyomatosis.
- MediastinitisNagaoka isExperienced. Learn about Mediastinitis.
- Metabolic AcidosisNagaoka isExperienced. Learn about Metabolic Acidosis.
- Neurotoxicity SyndromesNagaoka isExperienced. Learn about Neurotoxicity Syndromes.
- PneumoniaNagaoka isExperienced. Learn about Pneumonia.
- Pulmonary FibrosisNagaoka isExperienced. Learn about Pulmonary Fibrosis.
- SarcoidosisNagaoka isExperienced. Learn about Sarcoidosis.
- Tracheobronchopathia Osteoplastica
- VasoconstrictionNagaoka isExperienced. Learn about Vasoconstriction.